Neuropathic Pain Market Share

Statistics for the 2023 & 2024 Neuropathic Pain market share, created by Mordor Intelligence™ Industry Reports. Neuropathic Pain share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Neuropathic Pain Industry

The neuropathic pain market is moderately competitive and consists of a few major players. Companies like Grünenthal, Mallinckrodt Pharmaceuticals, GlaxoSmithKline PLC, J Pfizer Inc., Cipla Inc., Glenmark, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd occupy a substantial market share.

Neuropathic Pain Market Leaders

  1. Grünenthal

  2. Mallinckrodt Pharmaceuticals

  3. Pfizer, Inc.

  4. Novartis AG

  5. Teva Pharmaceutical Industries Ltd.

*Disclaimer: Major Players sorted in no particular order

Neuropathic Pain Market Concentration

Neuropathic Pain Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)